A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Clinical trial NCT06951711 · RECRUITING

Trial details

NCT number: NCT06951711
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder Type I With Mania or Mania With Mixed Features

Start date: 2025-06-13
Primary completion: 2026-11-02
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.